Bas L. Van Der Hoeven

发表

Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation.

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2014, International journal of cardiology.

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.

T. Stijnen, J. Wouter Jukema, A. Hassan, 2010, European heart journal.

Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.

Katja Zeppenfeld, Hein Putter, Jouke Dijkstra, 2008, JACC. Cardiovascular interventions.

Influence of coronary vessel dominance on short- and long-term outcome in patients after ST-segment elevation myocardial infarction.

Jeroen J. Bax, Bas L van der Hoeven, M. Schalij, 2015, European heart journal.

Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, The American journal of cardiology.

Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.

Jeroen J. Bax, Bas L van der Hoeven, M. Schalij, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Diagnostic accuracy of 64-slice multislice computed tomography in the noninvasive evaluation of significant coronary artery disease.

Jeroen J. Bax, J. Schuijf, H. Lamb, 2006, The American journal of cardiology.

A second shell residue modulates a conserved ATP-binding site with radically different affinities for ATP.

Bas L van der Hoeven, P. Bond, A. Krah, 2020, Biochimica et biophysica acta. General subjects.

Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.

G. Stone, H. Suryapranata, M. Schalij, 2013, The American journal of cardiology.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

G. Stone, H. Suryapranata, M. Schalij, 2012, Archives of internal medicine.

Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study).

D. Atsma, J. Jukema, Bas L van der Hoeven, 2010, The American journal of cardiology.

Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.

H. Putter, D. Atsma, J. Jukema, 2008, Journal of the American College of Cardiology.

Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction.

H. Putter, J. Jukema, J. Verschuren, 2013, International journal of cardiology.

Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, The American journal of cardiology.

In-hospital major bleeding and its clinical relevance in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.

Bas L van der Hoeven, M. Schalij, S. Cannegieter, 2013, The American journal of cardiology.

Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study.

D. Atsma, J. Jukema, S. Bergheanu, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Myocardial Infarction Occurs with a Similar 24 h Pattern in the 4G/5G Versions of Plasminogen Activator Inhibitor-1

J. Vandenbroucke, S. le Cessie, J. Jukema, 2009, Chronobiology international.

Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients.

J. Jukema, Bas L van der Hoeven, M. Schalij, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stents

J. Jukema, A. Hassan, S. Bergheanu, 2009, Acta cardiologica.

Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.

D. Atsma, J. Jukema, Bas L van der Hoeven, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Time course, predictors and clinical implications of stent thrombosis following primary angioplasty

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2013, Thrombosis and Haemostasis.

CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.

H. Putter, D. Atsma, J. Jukema, 2008, Journal of molecular and cellular cardiology.